Ascertaining the pathogenicity and clinical relevance of genetic mutations is a longstanding challenge across human disease. This is particularly relevant for genes with many variants of unknown significance (VUS), such as PRPH2-retinopathy, where complex variable phenotype patterns and limited genotype correlations hinder application of precision-medicine therapies. Recent AI-based pathogenicity tools, while powerful, may be limited by insufficient mechanistic or phenotypic training data.
Advancing genetic pathogenicity prediction with three-dimensional proteoform-phenotype analysis
calendar_today
October 9, 2026
person
Sun, Y. J., Velez, G., Li, A. S., Kumar, A., Vu, J. T., Phillips, C. J., Rasmussen, D. K., Oh, J. K., Costa, M. G. S., Tsang, S. H., Sun, Y., Bassuk, A. G., Mahajan, V. B.
domain
medrxiv